Prior authorization for hospice meds meets opposition

06/17/2014 | Hill, The

More than 240 hospice advocates lobbied in support of a congressional letter asking CMS Administrator Marilyn Tavenner to remove a new prior authorization process for hospice drugs, saying that it restricts access to necessary treatment at the end of life. "We appreciate your agency's effort to protect taxpayer dollars by making sure that Medicare is not paying double for prescription drugs for beneficiaries who have elected hospice care," the letter reads. "However, any efforts to address this concern with hospice providers and the Medicare Part D plans cannot be done at the expense of vulnerable patients seeking end-of-life care."

View Full Article in:

Hill, The

Published in Briefs: